We are live on ! Find out more
VSTM icon

Verastem
VSTM

109 hedge funds and large institutions have $108M invested in Verastem in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 29 increasing their positions, 30 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

358% more call options, than puts

Call options by funds: $165K | Put options by funds: $36K

0.75% more ownership

Funds ownership: 4.9% → 5.65% (+0.75%)

3% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 30

11% less funds holding

Funds holding: 122 → 109 (-13)

15% less capital invested

Capital invested by funds: $127M → $108M (-$19M)

60% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 20

Holders
109
Holders Change
-13
Holders Change %
-10.66%
% of All Funds
1.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
29
Reduced
30
Closed
20
Calls
$165K
Puts
$36K
Net Calls
+$129K
Net Calls Change
-$197K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$20M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$4.76M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$614K
4
Renaissance Technologies
Renaissance Technologies
New York
+$488K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$440K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.25M
2
OM
Opaleye Management
Massachusetts
-$1.84M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$752K
4
UOC
UBS O'Connor
Illinois
-$625K
5
IC
Ikarian Capital
Texas
-$265K

VSTM Hedge Fund Activity: Q3 2022 in Review

109 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Verastem (VSTM) for Q3 2022, worth a combined $108M — down 15% from $127M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of VSTM and 8 opened new positions — a net loss of 12 holders — while 30 trimmed existing stakes and 29 added.

The largest buyer was OrbiMed, opening a new position worth an estimated $20M. The largest seller was Millennium Management, cutting an estimated $2.25M.

  • 109 institutional investors held Verastem (VSTM) as of Q3 2022, down from 122 in Q2 2022.
  • Funds reported $108M of Verastem stock for Q3 2022, down 15% quarter-over-quarter.
  • 8 funds opened new Verastem positions in Q3 2022 and 20 closed out, a net change of -12 holders.
  • The largest Verastem buyer in Q3 2022 was OrbiMed, an estimated $20M added.
  • The largest Verastem seller in Q3 2022 was Millennium Management, an estimated $2.25M sold.

Based on aggregated 13F filings for Q3 2022.